Gotham Therapeutics and ZoBio Achieve Significant Milestone in Epitranscriptomic Drug Discovery Collaboration Read more
Registration is now open for the inaugural Wearable Injectors and Connected Devices Conference 2019 Read more
Lilly’s Mirikizumab Met Primary Endpoint and Key Secondary Endpoints in Phase 2 Study, Including Reductions of Gastrointestinal Lesions Read more
Kazia Enters Clinical Collaboration for Metastatic Brain Cancer with Alliance for Clinical Trials in Oncology Read more
Catalent Completes Acquisition of Gene Therapy Leader Paragon Bioservices, Inc. for $1.2 Billion Read more
New data show Symbicort reduces attacks in mild asthma when used as an anti-inflammatory reliever Read more